BUSINESS

• Wholesalers Hails Gilead Ambition to Unearth More Hep C Patients through Collaboration
  October 26, 2016

• Mitsubishi Tanabe Lifts Earnings Outlook on Simponi, Vaccines
  October 26, 2016

• Prof. Yamanaka Eager to Bridge Valley of Death through Takeda Collaboration
  October 25, 2016

• Astellas Wins Xtandi Label Update in US for PFS Extension
  October 25, 2016

• Sunovion Completes Acquisition of Cynapsus
  October 25, 2016

• Shionogi Ups Earnings Forecast for April-September
  October 25, 2016

• Ono Files Patent Infringement Suit over Keytruda
  October 25, 2016

• Nihon Generic Takes Over 3 Brands from MSD
  October 24, 2016

• Prasugrel Disappoints in PIII Study for Ischemic Cerebrovascular Disease
  October 24, 2016

• 295 Staffers Applied for Voluntary Redundancy: Sumitomo Dainippon
  October 24, 2016

• Daiichi Sankyo Stops Patient Enrollment for Pexidartinib PIII, but Continues Study
  October 24, 2016

• Oncolys, DNA Chip Research Team Up to Study Potential of TelomeScan as Companion Diagnostic for CRPC
  October 24, 2016

• Kipres Generics Might Add Bronchial Asthma Indication before December Listing
  October 21, 2016

• Janssen Files Anti-IL-6 Antibody Sirukumab for RA
  October 21, 2016

• Humira Biosimilar Hits Primary Endpoint in Global PIII: Fujifilm, Kyowa Kirin
  October 20, 2016

• Kaketsuken’s Biz Transfer Talks Fall Apart, but Minister Nixes Its Continued Operations
  October 20, 2016

• Astellas Calls Off Biz Transfer Talks with Kaketsuken
  October 19, 2016

• UK’s Clinigen Launches Japan Operations with Takeover of Foscavir
  October 19, 2016

• Kaketsuken Denies Unauthorized Manufacturing or Cover-up, Blames Ambiguity in Approval Doc
  October 19, 2016

• Entyvio’s Real-World Data Support Trial Results: Takeda
  October 18, 2016

ページ

• « 先頭
• ‹ Prev
• …
• 464
• 465
• 466
• 467
• 468
• 469
• 470
• 471
• 472
• …
• Next ›
• 最終 »